BioCentury
ARTICLE | Company News

CyDex Inc., Teva deal

May 5, 2003 7:00 AM UTC

CyDex granted TEVA global rights to use CyDex's Captisol drug delivery technology for use with TEVA's TV-4710, a peptide based on the sequence of the complementarity determining region 1(CDRI) of an a...